METHYLDOPA FOR TREATMENT OF HYPERTENSION

[1] BAYLISS RIS, 1962, LANCET, V1, P763

[2] EFFECT OF ALPHA-METHYL DOPA IN SEVERE AND MALIGNANT HYPERTENSION [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 179 (09): : 673 - +

[3] DOLLERY CT, 1962, LANCET, V1, P759

[4] FAULK WT, 1957, P MAYO CLIN, V32, P405

[5] CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINE [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 88 (04) : 1011 - 1020

[6] ACTIONS OF THE DECARBOXYLASE INHIBITOR, ALPHA-METHYL-3,4-DIHYDROXYPHENYLALANINE, IN THE DOG [J]. NATURE, 1960, 188 (4749) : 502 - 504

[7] HALLWRIGHT G P, 1961, N Z Med J, V60, P567

[8] HESS SM, 1961, VIVO J PHARMACOL EXP, V134, P129

[9] IRVINE ROH, 1962, LANCET, V1, P300

[10] TRANSAMINASE ACTIVITY IN HUMAN BLOOD [J]. JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (01) : 126 - 133

[1] BAYLISS RIS, 1962, LANCET, V1, P763

[2] EFFECT OF ALPHA-METHYL DOPA IN SEVERE AND MALIGNANT HYPERTENSION [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 179 (09): : 673 - +

[3] DOLLERY CT, 1962, LANCET, V1, P759

[4] FAULK WT, 1957, P MAYO CLIN, V32, P405

[5] CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINE [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 88 (04) : 1011 - 1020

[6] ACTIONS OF THE DECARBOXYLASE INHIBITOR, ALPHA-METHYL-3,4-DIHYDROXYPHENYLALANINE, IN THE DOG [J]. NATURE, 1960, 188 (4749) : 502 - 504

[7] HALLWRIGHT G P, 1961, N Z Med J, V60, P567

[8] HESS SM, 1961, VIVO J PHARMACOL EXP, V134, P129

[9] IRVINE ROH, 1962, LANCET, V1, P300

[10] TRANSAMINASE ACTIVITY IN HUMAN BLOOD [J]. JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (01) : 126 - 133